All
Search
Images
Videos
Shorts
Maps
News
More
Shopping
Flights
Travel
Notebook
Report an inappropriate content
Please select one of the options below.
Not Relevant
Offensive
Adult
Child Sexual Abuse
Top suggestions for Nasdaq Biotechnology
Nasdaq
Chien
Nasdaq
Influenceur
Carte Nasdaq
Live
ETF
Nasdaq
Nasdaq
Tieks Video
4Bvd
Nasdaq
Nasdaq
100
Nasdaq
Samos
Cosmetics
Biotechnology
Cappuccino
Nasdaq
Biotechnology
Stocks
Nasdaq
Riadh
Index 75
Nasdaq
Carte Bleu
Nasdaq
Nasdaq
Et 4Bdv
Code Carte
Nasdaq
La Chiennete
Nasdaq
Nasdaq
Le Piege
HTL Biotechnology
Javen E
Nasdaq
100 000
Length
All
Short (less than 5 minutes)
Medium (5-20 minutes)
Long (more than 20 minutes)
Date
All
Past 24 hours
Past week
Past month
Past year
Resolution
All
Lower than 360p
360p or higher
480p or higher
720p or higher
1080p or higher
Source
All
Dailymotion
Vimeo
Metacafe
Hulu
VEVO
Myspace
MTV
CBS
Fox
CNN
MSN
Price
All
Free
Paid
Clear filters
SafeSearch:
Moderate
Strict
Moderate (default)
Off
Filter
Nasdaq
Chien
Nasdaq
Influenceur
Carte Nasdaq
Live
ETF
Nasdaq
Nasdaq
Tieks Video
4Bvd
Nasdaq
Nasdaq
100
Nasdaq
Samos
Cosmetics
Biotechnology
Cappuccino
Nasdaq
Biotechnology
Stocks
Nasdaq
Riadh
Index 75
Nasdaq
Carte Bleu
Nasdaq
Nasdaq
Et 4Bdv
Code Carte
Nasdaq
La Chiennete
Nasdaq
Nasdaq
Le Piege
HTL Biotechnology
Javen E
Nasdaq
100 000
Abivax intègrera le Nasdaq Biotechnology Index
3 months ago
zonebourse.com
NASDAQ Biotechnology 차트 - Investing.com
Jan 8, 2013
investing.com
iShares Nasdaq Biotechnology ETF Experiences Big Outflow
Oct 10, 2019
nasdaq.com
FibroBiologics (Nasdaq: FBLG) 30 Second Investor Overview | IP Portfolio and Cell Science Platform | RedChip Companies
6.7K views
3 months ago
linkedin.com
Trinity Biotech (Nasdaq: TRIB) 30-Second Investor Summary: AI Glucose Wearable Platform | RedChip Companies
7K views
1 month ago
linkedin.com
0:25
Jupiter Neurosciences, Inc. (NASDAQ: JUNS), a B2i Digital Featured Company, announced that management will present at the BIO Investment and Growth Summit 2026, hosted by the Biotechnology Innovation Organization (BIO), taking place March 2 to 3, 2026, in Miami Beach, Florida. The Company’s corporate presentation is scheduled for March 2, 2026, at 2:30 PM Eastern. At BIO, Jupiter will discuss its FDA-cleared Phase IIa clinical program in Parkinson’s disease. The U.S. Food and Drug Administration
1.2K views
1 month ago
Facebook
B2i Digital
Nasdaq Explained: History, Trading System, and Financial Insights
Mar 20, 2024
investopedia.com
NovaBridge Biosciences(NasdaqGM: NBP) added to NASDAQ Biotechnology Index
3 months ago
marketscreener.com
IGM Biosciences, Inc.(NasdaqGS: IGMS) dropped from NASDAQ Biotechnology Index
8 months ago
marketscreener.com
Invesco Nasdaq Biotechnology ETF Rings the Nasdaq Stock Market Opening Bell
Jan 8, 2024
nasdaq.com
Biotechnology
Mar 23, 2020
gatech.edu
Upstream Bio Rings the Nasdaq Stock Market Opening Bell
Oct 23, 2024
nasdaq.com
Nasdaq Financial Technology News & Insights
Nov 15, 2024
nasdaq.com
Abivax va intégrer l'indice américain Nasdaq Biotechnology
3 months ago
zonebourse.com
Biotechnology and Synthetic Biology
Nov 23, 2023
stanford.edu
Biotechnology Master's Degree Program | Harvard Extension School
4 months ago
harvard.edu
Biotechnology Innovation Organization | LinkedIn
Jan 6, 2016
linkedin.com
BioNTech SE Rings the Opening Bell in Celebration of its IPO
Oct 11, 2019
nasdaq.com
0:15
🔬@Nasdaq remains home to today’s top & emerging biotech companies. Here’s what you need to know about the latest trends shaping the biotech sector in 2025 from Jordan Saxe, Head of Healthcare Listings at Nasdaq. Read more at the #LinkInBio. | Nasdaq
731 views
Mar 10, 2025
Facebook
Nasdaq
Top mid-cap pharma stocks powering the NASDAQ Biotech Index
Aug 12, 2021
kalkinemedia.com
Trends in Biotechnology
9 months ago
deloitte.com
Sana joins Nasdaq with blockbuster $587M IPO
Feb 4, 2021
geekwire.com
0:20
Unicycive Therapeutics (Nasdaq: UNCY) recently released an updated company presentation highlighting several financial aspects of the biotechnology company. Unicycive Therapeutics is a B2i Digital Featured Company. View their comprehensive profile at https://b2idigital.com/unicycive. Highlights from the investor presentation include: • Unaudited cash and cash equivalents of $22.3 million as of June 30, 2025 • Cash runway currently expected into 2H 2026 • Potential future funding of up to $102 mi
1.4K views
6 months ago
Facebook
B2i Digital
NetScientific portfolio company PDS Biotechnology to advance lead candidate PDS0101 with term loan
Sep 19, 2022
proactiveinvestors.com
11:53
This sector will BOMB the stock market in 2026 (TOP 5)
255 views
1 month ago
YouTube
Investologia
GT Biopharma: Inside This Emerging NK Cell Biotech | RedChip Companies
4 months ago
linkedin.com
9:52
Best Nasdaq-100 ETFs (US and Irish) | QQQ, QQQM ETF
12.3K views
Jul 1, 2022
YouTube
Ziet Invests
The Nasdaq Biotechnology Index & Invesco Nasdaq Biotechnology ETF Ring the Nasdaq Stock Market Opening Bell
Jan 16, 2025
nasdaq.com
7:37
Plant Biotech Lab Tour
91.9K views
Dec 18, 2019
YouTube
Exploring Plants
1:02
Nasdaq | LIST
3.7K views
Feb 11, 2015
YouTube
Nasdaq
See more
More like this
Feedback